AI NewsStrip Out AI and the S&P 500 Looks Very Different, Goldman Index...

Strip Out AI and the S&P 500 Looks Very Different, Goldman Index Shows

The S&P 500 has gained 18.3% in six months, against 6.7% for Goldman Sachs’ index excluding artificial intelligence (AI) enablers. A chip-led AI rally pushed the benchmark to a record, while that index sits 6.4% below its high.

The S&P 500 and Nasdaq Composite both closed at records on Tuesday. Goldman’s ex-AI index, by contrast, peaked in August.

Where did the S&P 500 and its ex-AI version split?

The S&P 500 gained 18.3% over six months to 7,818.93 at Tuesday’s close, Google Finance data show. The ex-AI index, ticker SPXXAI, gained 6.7% to 3,123.24. The gap is 11.6 percentage points.

Goldman built the index in February so clients could hedge AI exposure, Axios reported. It excludes stocks the bank deems AI enablers, about 45% of the S&P 500 at launch.

The ex-AI index sits 6.4% below its 52-week high of 3,337.19. Meanwhile, the S&P 500 sits 0.3% below its own.

Chip stocks supplied the latest push. AMD, Marvell, Synopsys, and Cadence Design Systems each gained 20% or more in about 20 trading days, CNBC reported.

Still, Schwab’s Kevin Gordon has noted that the average stock fell 14% peak to trough since early August.

Could power stocks become the next leg of the AI trade?

Jan van Eck, CEO of asset manager VanEck, said chips were the first stage of the AI trade. He calls power producers and nuclear energy the second stage, or the AI 2.0 trade.

That group has lagged this year over political concerns about data center growth, he said. Yet power producer Constellation Energy jumped 12.3% on Tuesday after Alphabet signed a power deal with it.

Van Eck said the deal may mark a bottom for the group. However, a prediction market he cited puts the odds of one approved nuclear plant below 10% this year.

“I think when that happens this dry spell for the AI 2.0 trade will be over.”

Jan van Eck, CEO of VanEck, via CNBC

The split suggests the benchmark’s records now rest on AI-linked stocks. Third-quarter results from the largest cloud spenders may show whether that support holds.

- Advertisement -spot_img

More From UrbanEdge

Will SpaceX’s $40B Nvidia Bet Help or Hurt the Stock After a 16% Run?

SpaceX plans $40 billion in debt for Nvidia chips after a 16% five-day rally. Here is what it may mean for SPCX shares. The post Will SpaceX's $40B Nvidia Bet Help or Hurt the Stock After a 16% Run? appeared first on BeInCrypto.

Wells Fargo Hands Meta a $1,000 Target and a Warning About 2027 Earnings

Wells Fargo raised its Meta Platforms stock price target to $1,000 from $796 this week. The new figure ranks among the highest targets on Wall Street. The bank kept its overweight rating. However, the same note expects Meta’s earnings to bottom out before its artificial intelligence (AI) push shows up in estimates. Wells Fargo Doubles…

Bitcoin Slide Wipes Out Over $400 Million in Crypto Longs: Reset or Warning?

Bitcoin liquidations hit $403.58M in longs in an hour, yet open interest still sits at $150B. Reset or warning? The post Bitcoin Slide Wipes Out Over $400 Million in Crypto Longs: Reset or Warning? appeared first on BeInCrypto.

S&P 500 Breaks Records But Analysts Split on Whether Rally Can Broaden

The S&P 500 record high above 7,800 splits money managers on whether the rally can broaden beyond big tech and Fed hikes. The post S&P 500 Breaks Records But Analysts Split on Whether Rally Can Broaden appeared first on BeInCrypto.

Abstract’s Shutdown Lifts the Pudgy Penguins NFT Floor but Weighs on Its Token

Abstract, a blockchain built for consumer crypto apps, is shutting down after almost three years. It joins hundreds of crypto projects that have already closed in 2026. The news has turned attention back to Pudgy Penguins. The non-fungible token (NFT) floor price climbed, while its token, Pudgy Penguins (PENGU), moved the other way. Tens of…

Goldman Sachs Says China Biotech Is Where Big Pharma Is Shopping Now

Goldman Sachs analyst Salveen Richter says big pharma is shopping in China biotech as $440 billion in drugs lose patents. The post Goldman Sachs Says China Biotech Is Where Big Pharma Is Shopping Now appeared first on BeInCrypto.

BTCC Exchange Launches Refreshed Trust Center: Alex Hung on Why Security Has to Come First

BTCC, the world’s longest-serving cryptocurrency exchange and Platinum Sponsor of TOKEN2049 Singapore, today announced the launch of its refreshed Trust Center. The relaunch reflects a view that Alex Hung, Head of Operations, has held since BTCC’s earliest days: that security has to be built, tested, and proven over time. 15 Years of Building Trust As…

Crypto Is Winning in Washington Despite Clarity Act Failure, Says Policy Chief

Solana Policy Institute's Kristin Smith says crypto is winning in Washington as SEC and CFTC rules race a 2028 deadline. The post Crypto Is Winning in Washington Despite Clarity Act Failure, Says Policy Chief appeared first on BeInCrypto.

Hyperliquid Calls Singapore Home — But Does It Have a License?

Hyperliquid confirms Singapore registration, yet MAS reportedly won't claim jurisdiction. See what it means for HYPE traders. The post Hyperliquid Calls Singapore Home — But Does It Have a License? appeared first on BeInCrypto.
- Advertisement -spot_img